Maciukiewicz Malgorzata, Pawlak Joanna, Kapelski Pawel, Łabędzka Magdalena, Skibinska Maria, Zaremba Dorota, Leszczynska-Rodziewicz Anna, Dmitrzak-Weglarz Monika, Hauser Joanna
Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Rokietnicka St. 8, 60-806, Poznan, Poland.
Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Psychiatr Q. 2016 Sep;87(3):501-13. doi: 10.1007/s11126-015-9405-z.
Schizophrenia (SCH) is a complex, psychiatric disorder affecting 1 % of population. Its clinical phenotype is heterogeneous with delusions, hallucinations, depression, disorganized behaviour and negative symptoms. Bipolar affective disorder (BD) refers to periodic changes in mood and activity from depression to mania. It affects 0.5-1.5 % of population. Two types of disorder (type I and type II) are distinguished by severity of mania episodes. In our analysis, we aimed to check if clinical and demographical characteristics of the sample are predictors of symptom dimensions occurrence in BD and SCH cases. We included total sample of 443 bipolar and 439 schizophrenia patients. Diagnosis was based on DSM-IV criteria using Structured Clinical Interview for DSM-IV. We applied regression models to analyse associations between clinical and demographical traits from OPCRIT and symptom dimensions. We used previously computed dimensions of schizophrenia and bipolar affective disorder as quantitative traits for regression models. Male gender seemed protective factor for depression dimension in schizophrenia and bipolar disorder sample. Presence of definite psychosocial stressor prior disease seemed risk factor for depressive and suicidal domain in BD and SCH. OPCRIT items describing premorbid functioning seemed related with depression, positive and disorganised dimensions in schizophrenia and psychotic in BD. We proved clinical and demographical characteristics of the sample are predictors of symptom dimensions of schizophrenia and bipolar disorder. We also saw relation between clinical dimensions and course of disorder and impairment during disorder.
精神分裂症(SCH)是一种复杂的精神疾病,影响着1%的人口。其临床表型具有异质性,包括妄想、幻觉、抑郁、行为紊乱和阴性症状。双相情感障碍(BD)指情绪和活动从抑郁到躁狂的周期性变化。它影响着0.5 - 1.5%的人口。两种类型的双相情感障碍(I型和II型)根据躁狂发作的严重程度来区分。在我们的分析中,我们旨在检验样本的临床和人口统计学特征是否是双相情感障碍和精神分裂症病例中症状维度出现的预测因素。我们纳入了443名双相情感障碍患者和439名精神分裂症患者的总样本。诊断基于DSM-IV标准,采用针对DSM-IV的结构化临床访谈。我们应用回归模型来分析OPCRIT中的临床和人口统计学特征与症状维度之间的关联。我们将先前计算出的精神分裂症和双相情感障碍维度作为回归模型的定量特征。在精神分裂症和双相情感障碍样本中,男性性别似乎是抑郁维度的保护因素。疾病前存在明确的心理社会应激源似乎是双相情感障碍和精神分裂症中抑郁和自杀领域的危险因素。描述病前功能的OPCRIT项目似乎与精神分裂症中的抑郁、阳性和紊乱维度以及双相情感障碍中的精神病性维度相关。我们证明了样本的临床和人口统计学特征是精神分裂症和双相情感障碍症状维度的预测因素。我们还观察到临床维度与疾病过程以及疾病期间的损害之间的关系。